Evidence map›Paper›PMID 34697432›Full record

SynthesisProstate cancer and prostatic diseases2022

Comparison of Retzius-sparing and conventional robot-assisted laparoscopic radical prostatectomy regarding continence and sexual function: an updated meta-analysis.

Junyan Liu, Jindong Zhang, Zongke Yang, Qingyuan Liu, Weiyang Zhang, Zizhen Qing, Delin Wang

Abstract readMeta-AnalysisReview
PubMed Publisher
In one paragraph

Synthesis in Prostate cancer and prostatic diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Junyan Liu *Chongqing Medical University, Chongqing, 400016, China.
Jindong Zhang *Department of Urology, the First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.ORCID http://orcid.org/0000-0001-7914-7467
Zongke YangDepartment of Urology, Dianjiang People's Hospital of Chongqing, Chongqing, 408399, China.
Qingyuan LiuDepartment of Urology, the First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.
Weiyang ZhangDepartment of Urology, the First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.
Zizhen QingDepartment of Urology, the First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.
Delin WangDepartment of Urology, the First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China. dlwangws@sina.com.ORCID http://orcid.org/0000-0003-0689-3199

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

abstact

backgroundStudies comparing C-RARP and RS-RARP have reported different results and the choice between the two operation methods remains controversia.

methodsWe present the meta-analysis on the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-analyses) guidelines. The meta-analysis was carried out using Review Manager 5.3 (Cochrane Collaboration, Oxford, United Kingdom) and Stata SE 14.0. The mean difference (MD) with 95% confidence intervals (CI) were used to describe the results of continuous data; odds ratio (OR) with 95% CI were used to describe dichotomous data. Statistical significance was set at P < 0.05.

resultsThe meta-analysis revealed that RS-RARP had a statistically significant advantage in terms of continence recovery immediately after operation (OR: 0.40, 95% CI: 0.20-0.77; P = 0.007) (Fig. 2a), after 1 month (OR: 0.17, 95% CI: 0.10-0.29; P < 0.00001) (Fig. 2b), after 3 months (OR: 0.18, 95% CI: 0.09-0.36; P < 0.00001) (Fig. 2c), after 6 months (OR: 0.26, 95% CI: 0.15-0.46; P < 0.00001) (Fig. 2d) and after 12 months (OR: 0.50, 95% CI: 0.28-0.89; P = 0.02) (Fig. 2e).

conclusionsThis meta-analysis found that RS-RARP had better postoperative continence recovery than C-RARP, while sexual function recovery rates were not significantly different. There were also no significant differences in operation time, intraoperative blood loss, length of stay, positive margin rate and complications.

Indexed as

LaparoscopyProstatic NeoplasmsRoboticsRobotic Surgical ProceduresHumansMaleProstatectomyTreatment Outcome

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.